| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |